Long-Term Treatment with 300IR 5-Grass Pollen Sublingual Tablet in Grass Pollen Allergic Subjects: Safety Outcome Year after Year

被引：0
|
作者：
Golden, David B. K. [1 ]
Fahrenholz, John M. [2 ]
Renahan, Kevin E. [3 ]
Khairallah, Sandrine [4 ]
Abiteboul, Kathy [4 ]
机构：
[1] Medstar Franklin Sq Med Ctr, Baltimore, MD USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Stallergenes Greer, Cambridge, MA USA
[4] Stallergenes Greer, Antony, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.148
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
191
引用
收藏
页码：AB60 / AB60
页数：1
相关论文
共 50 条
  • [41] Safety Of 300IR 5-Grass Tablet In Grass Pollen-Allergic Children With Or Without Controlled Asthma: Further Data From A Post-Marketing Observational Study
    Golden, David B. K.
    Gerstlauer, Michael
    Szepfalusi, Zsolt
    De Blic, Jacques
    Geng, Bob
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB198 - AB198
  • [42] SAFETY OF THE 5-GRASS POLLEN SUBLINGUAL TABLET IN MONO- AND POLY-SENSITIZED PATIENTS WITH GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS.
    Golden, D. B.
    Abiteboul, K.
    Zeldin, R. K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A99 - A99
  • [43] Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis
    Zeldin, Robert K.
    Amistani, Yann
    Cognet-Sice, Josiane
    Abiteboul, Kathy
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [44] Sustained and post-treatment efficacy of a 5-grass pollen allergen extract sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Zeldin, R. K.
    Melac, M.
    Amistani, Y.
    Didier, A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (03) : 298 - 298
  • [45] Assessment of timothy grass-specific serum IgE and IgG4 in a long-term study of 300IR five-grass pollen sublingual tablet
    Malling, H.
    Cadic, V
    Cognet-Sice, J.
    Zeldin, R.
    ALLERGY, 2012, 67 : 418 - 418
  • [46] Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
    Didier, Alain
    Malling, Hans-Jorgen
    Worm, Margitta
    Horak, Friedrich
    Sussman, Gordon L.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2015, 5
  • [47] Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis
    Gerstlauer, Michael
    Szepfalusi, Zsolt
    Golden, David
    Geng, Bob
    de Blic, Jacques
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (01) : 70 - 80
  • [48] Modalities of use and tolerance of a 300IR 5-grass pollen tablet treatment in real life in patients consulting allergology specialists in France
    Devillier, P.
    Serrano, E.
    Lheritier-Barrand, M.
    Chanal, I
    Migueres, M.
    ALLERGY, 2017, 72 : 160 - 161
  • [49] Impact of discontinuous administration of a 300IR sublingual tablet of five-grass-pollen extract on symptomatic treatment use
    Didier, A.
    Malling, H.
    Worm, M.
    Soulie, S.
    Abiteboul, K.
    Zeldin, R.
    ALLERGY, 2012, 67 : 415 - 415
  • [50] Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America
    Moingeon, Philippe
    Cox, Linda
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (06) : 617 - 623
12345